US EditionGlobant to Announce First Quarter 2026 Financial Results on May 14th
The company will report first-quarter 2026 results after market close and hold a conference call to discuss financial performance.
- TC Energy reported its first quarter 2026 financial results on May 1, reporting comparable EBITDA of $3.1 billion and segmented earnings of $2.2 billion, reflecting strong execution across its network.
- Record operational deliveries across the network drove results; Canadian Natural Gas Pipelines averaged 29.7 Bcf/d while U.S. Natural Gas Pipelines achieved 39.9 Bcf on Jan. 29, 2026.
- TC Energy's Board of Directors declared a quarterly dividend of $0.8775 per common share for the quarter ending June 30, 2026, while total liquidity reached $8,798 million as of March 31, 2026.
- Infrastructure development advances with the approved $1.5 billion Appalachia Supply Project and completed Berland River unit, expected operational in the second half of 2026.
- Management reaffirmed its 2026 outlook while maintaining 2028 financial targets and 2030 aspirations, though achievement depends on new technologies, renewable energy, and sustainable aviation fuel availability.
61 Articles
61 Articles
The Toronto Star
Conifex Announces First Quarter 2026 Results Conference Call and Provides Operational Update
VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Conifex Timber Inc. (“Conifex”) (TSX: CFF) announced today that it plans to release its first quarter 2026 results before market open
Mohave Daily News
The Prescott TimesCisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results
SAN JOSE, Calif., May 1, 2026 /PRNewswire/ -- Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, May 13, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its third quarter fiscal year 2026 financial results for the…
The Laconia Daily Sun
INOVIO to Report First Quarter Financial Results on May 13, 2026
PLYMOUTH MEETING, Pa., May 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that its first quarter 2026…
Coverage Details
Bias Distribution
- 44% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
